KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Liabilities and Shareholders Equity (2016 - 2026)

Opko Health filings provide 17 years of Liabilities and Shareholders Equity readings, the most recent being $1.9 billion for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 12.76% to $1.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $7.8 billion, a 9.43% decrease, with the full-year FY2025 number at $1.9 billion, down 12.19% from a year prior.
  • Liabilities and Shareholders Equity hit $1.9 billion in Q1 2026 for Opko Health, down from $1.9 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.4 billion in Q2 2022 to a low of $1.9 billion in Q1 2026.
  • Median Liabilities and Shareholders Equity over the past 5 years was $2.1 billion (2025), compared with a mean of $2.1 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: rose 9.7% in 2024 and later decreased 12.76% in 2026.
  • Opko Health's Liabilities and Shareholders Equity stood at $2.2 billion in 2022, then decreased by 7.18% to $2.0 billion in 2023, then rose by 9.37% to $2.2 billion in 2024, then decreased by 12.19% to $1.9 billion in 2025, then decreased by 3.89% to $1.9 billion in 2026.
  • The last three reported values for Liabilities and Shareholders Equity were $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.0 billion (Q3 2025) per Business Quant data.